首页
400-620-6333
小分子和化合物库
选项
-
-
L-甲硫氨酸-¹³C₅,¹⁵NCAS号: 202468-47-1分子式: 13CH3S13CH213CH213CH(15NH2)13CO2H 分子量: 155.17SMILES: [13CH3]S[13CH2][13CH2][13C@H]([15NH2])[13C](O)=OInChIKey: FFEARJCKVFRZRR-XAFSXMPTSA-NInChI: 1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1/i1+1,2+1,3+1,4+1,5+1,6+1
-
吲哚-3-乙酸-2,2-d₂酸CAS号: 24420-86-8分子式: C10D2H7NO2 分子量: 177.2IUPAC Name: 2,2-dideuterio-2-(1H-indol-3-yl)acetic acidSMILES: C1=CC=C2C(=C1)C(=CN2)CC(=O)OInChIKey: SEOVTRFCIGRIMH-BFWBPSQCSA-NInChI: 1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)/i5D2
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAF
CAS号: 2050232-20-5SMILES: [Belantamab mafodotin] -
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号: 1401812-88-1 -
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: SMCC-DM1
CAS号: 1008106-64-6 -
Lutikizumab (anti-IL1a&IL1b)
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1791411-57-8 -
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: CL2A-SN-38
CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Ozoralizumab (anti-TNF-alpha&HSA)
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1167985-17-2 -
Sacituzumab govitecan (anti-TROP2)关联靶标: TACSTD2
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (Mc-VC-PAB-SN38)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Mc-VC-PAB-SN38
CAS号: 1491917-83-9SMILES: [Sacituzumab govitecan] -
Blinatumomab (anti-CD3&CD19)
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; CHO; ELISA, Flow Cytometry; Unconjugated
- 种属反应性: 人(Human)
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 853426-35-4 -
Brentuximab vedotin (anti-CD30)关联靶标: TNFRSF8
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号: 914088-09-8SMILES: [Brentuximab vedotin]
